Keywords: پروستاسیکلین; ERA; endothelin receptor antagonist; IPAH; idiopathic pulmonary arterial hypertension; PAH; pulmonary arterial hypertension; PDE; phosphodiesterase; SC; subcutaneous; 6MWT; 6-minute walk test; Subcutaneous prostanoid; Pediatric treatment; Pulmonary hypert
مقالات ISI پروستاسیکلین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پروستاسیکلین; pulmonary artery hypertension; lung hypoplasia; prostacyclin; BNP; B-type natriuretic peptide; CDH; Congenital diaphragmatic hernia; ECMO; Extracorporeal membrane oxygenation; LHR; Lung area to head circumference ratio; RVSP; Right ventricular systolic pr
Keywords: پروستاسیکلین; RA; rheumatoid arthritis; RF; rheumatoid factor; ACPA; anti-citrullinated protein antibodies; AA; arachidonic acid; PG; prostaglandins; LT; leukotrienes; TX; thromboxanes; LX; lipoxins; NSAID; non steroidal anti-inflammatory drugs; COXIB; COX-2 selective
Keywords: پروستاسیکلین; IFN; interferon; TMA; thrombotic microangiopathy; HUVECs; human umbilical vein endothelial cells; IFNAR; IFN-α/β receptor; JAKs; Janus kinases; STAT; signal transducer and activator of transcription; mAb; monoclonal antibody; VEGF; vascular endothelial
Keywords: پروستاسیکلین; Pulmonary hypertension; Pulmonary arterial hypertension; BMPR2; REVEAL Registry; Phosphodiesterase-5 inhibitors; Endothelin receptor antagonists; Prostacyclin;
Keywords: پروستاسیکلین; microvascular dysfunction; myocardial blood flow; omental flap; ONO-1301; prostacyclin; CFR; coronary flow reserve; CS; circumferential strains; CSR; circumferential strain rates; FGF; fibroblast growth factor; HGF; hepatocyte growth factor; IMR; index of
Keywords: پروستاسیکلین; 15-PGDH; 15-hydoxyprostaglandin dehydrogenase; AA; arachidonic acid; AF; atrial fibrillation; AKI; acute kidney injury; Akt; alpha serine/threonine-protein kinase; ALA; alpha-linolenic acid; AMD; age-related macular degeneration; Ang II; angiotensin II; B
Keywords: پروستاسیکلین; Pulmonary arterial hypertension; Endothelin receptor antagonist; Prostacyclin; Nitric oxide; Dose titration; Specialty pharmacy; ERA; endothelin receptor antagonist; ET-1; endothelin 1; PAH; pulmonary arterial hypertension; PAWP; pulmonary artery wedge pr
Keywords: پروستاسیکلین; ADP/ATP; adenosine di/tri phosphate; ApL; antiphospholipid; BTG; beta-thrombomodulin; COX; cycloâoxygenase; CVD; cardiovascular disease; DAMP; damage-associated molecular patterns; EC; endothelial cells; ECM; extracellular matrix; ET-1; endothelin-1; HC
Keywords: پروستاسیکلین; Prostacyclin; Prostacyclin synthase; Carcinogenesis; Tumor; Peroxisome proliferator-activated receptor;
Keywords: پروستاسیکلین; Hypoxemia; Nitric oxide; Sildenafil; Milrinone; Prostacyclin; Bosentan;
Keywords: پروستاسیکلین; Infrainguinal bypass surgery; Perioperative oxygen; Extended warming; Prostacyclin; Hydroxyproline; Hyperspectral technology;
Keywords: پروستاسیکلین; Pulmonary hypertension; Anesthesia; Inhaled nitric oxide; Endothelin antagonists; Calcium channel blockers; Prostacyclin;
Keywords: پروستاسیکلین; Frostbite; Rewarming; Thrombolysis; Prostacyclin; rTPA; Gangrene; Amputation; Telemedicine;
Keywords: پروستاسیکلین; cfDNA; cell free DNA; Cit; citrullinated; dpa; days post-admission; HNE; human neutrophil elastase; ICU; intensive care unit; LPS; lipopolysaccharide; NET; neutrophil extracellular trap; PRP; platelet rich plasma; PI; propidium iodide; PGI2; prostacyclin;
Keywords: پروستاسیکلین; WHO; World Health Organization; Ppm; part per million; EPA; Environmental Protection Agency; BIS; Bureau of Indian Standards; ICMR; Indian Council of Medical Research; IS; Indian Standards; CF; carbon-fluoride; PGI2; prostacyclin; GABA; gamma-aminobutyric
Keywords: پروستاسیکلین; Pulmonary hypertension; Pulmonary arterial hypertension; Transition; Parenteral; Inhaled; Prostacyclin;
Keywords: پروستاسیکلین; bile duct ligation; cyclooxygenase; hepatic encephalopathy; liver cirrhosis; prostacyclin;
Keywords: پروستاسیکلین; Obstructive sleep apnea; Prostacyclin; Thromboxane; Continuous positive airway pressure;
Keywords: پروستاسیکلین; Hypertension; Endothelium; Vascular smooth muscle; Prostacyclin; Pregnancy;
Keywords: پروستاسیکلین; Meta-analysis; Pulmonary arterial hypertension; Endothelin receptor antagonists; Phosphodiesterase type 5 inhibitors; Prostanoids; Soluble guanylate cyclase stimulators; Prostacyclin;
Keywords: پروستاسیکلین; Arachidonic acid metabolism; Prostacyclin; Thromboxane-prostanoid receptors; Prostacyclin receptors; Contraction; Relaxation
Keywords: پروستاسیکلین; Hypoxia; Oxygen; Nitric oxide; Prostacyclin; Sildenafil; Bosentan; Iloprost; Milrinone;
Keywords: پروستاسیکلین; Pulmonary arterial hypertension; Echocardiography; Right heart catheterization; Prostacyclin; Phosphodiesterase inhibitor; Endothelin antagonist;
Keywords: پروستاسیکلین; Vasomotion; Prostacyclin; Endothelium-derived NO; PVAT; Vasoactive adipokine; EDHF; EDCF; Adventitia;
Keywords: پروستاسیکلین; Pulmonary hypertension; Chronic obstructive pulmonary disease; Interstitial lung disease; Obstructive sleep apnea; Endothelin receptor antagonist; Phosphodiesterase inhibitor; Prostacyclin; Soluble guanylate cyclase stimulator;
Keywords: پروستاسیکلین; Pulmonary artery hypertension; Endothelin; Prostacyclin;
Keywords: پروستاسیکلین; 2K-1C; two-kidney one-clip; ACE-Is; angiotensin converting enzyme inhibitors; AL; aliskiren; Ang II; angiotensin II; ANP; atrial natriuretic peptide; APTT; activated partial thromboplastin time; ARBs; AT1 receptor antagonists; ASA; aspirin; Fg; fibrinogen
Keywords: پروستاسیکلین; HILIC; CAD; Fatty acid; Prostacyclin; PGI2; Prostaglandin;
Keywords: پروستاسیکلین; Iontophoresis; Prostacyclin; Periodic current; Continuous current; Microcirculation
Keywords: پروستاسیکلین; DLCO; diffusing capacity of lung for carbon monoxide; FC; functional class; HR; hazard ratio; mPAP; mean pulmonary artery pressure; NT-proBNP; N-terminal pro-brain natriuretic peptide; PAH; pulmonary arterial hypertension; PG; prostacyclin; PH; pulmonary
Keywords: پروستاسیکلین; cardiac surgery; milrinone; epoprostenol; prostacyclin; cardiopulmonary bypass; pulmonary hypertension
Keywords: پروستاسیکلین; 5-HT; serotonin; AngII; angiotensin II; BMPRII; bone morphogenetic protein receptor II; EC; endothelial cell; ECM; extracellular matrix; ET; endothelin; FGF; fibroblast growth factor; MCP; monocyte chemoattractant protein; MIF; migration inhibitory factor
Keywords: پروستاسیکلین; Cyclooxygenase-2; Breast cancer metastasis; Cell migration; Prostacyclin; IP receptor
Keywords: پروستاسیکلین; Pig; Oviduct; Prostacyclin; hCG; eCG
Keywords: پروستاسیکلین; Right ventricular failure; acute right heart syndrome; pulmonary hypertension; ventriculoarterial coupling; inflammation; prostacyclin;
Keywords: پروستاسیکلین; Scleroderma; Raynaud phenomenon; Digital ischemia; Digital ulcer; Prostacyclin; Calcium channel blocker; Thermoregulatory vessels;
Keywords: پروستاسیکلین; Stem cells; Endothelial cells; Prostacyclin; Endothelin-1; Shear stress;
Keywords: پروستاسیکلین; Prostacyclin; Eicosanoid; Behavior; Memory; Anxiety;
Keywords: پروستاسیکلین; Grape seed procyanidin extract; Nitric oxide; Polyphenols; Prostacyclin; Spontaneously hypertensive rats;
Keywords: پروستاسیکلین; Ion channels; Prostacyclin; Endothelin receptor antagonists; Soluble guanylate cyclase stimulators; Sympathetic neurotransmitter; Pulmonary hypertension5-HT, 5-hydroxytryptamine, i.e. serotonin; ADM, adrenomedullin; ASIC, acid-sensing ion channel; BKCa, l
Keywords: پروستاسیکلین; Endothelial dysfunction; Pulmonary arterial hypertension; Prostacyclin; Endothelin receptor antagonist; Type 5 phosphodiesterase inhibitors; Kinase inhibitorsACVRL1, activin A receptor type II-like kinase-1; BMPR2, bone morphogenetic protein receptor type
Keywords: پروستاسیکلین; Prostaglandins; Prostacyclin; GPCR; Pharmacology; Signal transduction; Tissue distribution;
Keywords: پروستاسیکلین; ACE; angiotensin converting enzyme; ACh; acetyl-choline; BK; bradykinin; DAF-2 DA; 4,5-diaminofluorescein diacetate; DAPI; 4â²,6-diamidino-2-phenylindole; DMEM; Dulbecco's modified eagle's medium; DMSO; dimethylsulfoxide; FACS; fluorescence-activated cel
Keywords: پروستاسیکلین; frostbite; prostacyclin; thrombolytics; field treatment
Involvement of the NO/sGC/cGMP/K+ channels pathway in vascular relaxation evoked by two non-quinazoline α1-adrenoceptor antagonists
Keywords: پروستاسیکلین; 4-AP; 4-amynopiridine; AC; adenylyl cyclase; BPH; benign prostatic hyperplasia; COX; cyclooxygenase; DAG; diacylglycerol; EDHF; endothelium-derived hyperpolarizing factor; eNOS; endothelial NO synthase; GLI; glibenclamide; HAEC; human aortic endothelial c
Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway
Keywords: پروستاسیکلین; Ovarian cancer; Prostacyclin; Iloprost; Invasion; Matrix metalloproteinase-2;
Formaldehyde regulates vascular tensions through nitric oxide-cGMP signaling pathway and ion channels
Keywords: پروستاسیکلین; Formaldehyde; Thoracic aorta ring; Vascular tension; Ion channels; Signal pathway; 4-AP; 4-aminopyridine; ACh; acetylcholine; l-NAME; NG-nitro-l-arginine methyl ester; ACE; angiotensin-converting enzyme; VSMCs; vascular smooth muscle cells; BKCa; big-cond
Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease
Keywords: پروستاسیکلین; Thromboxane; Prostacyclin; Cyclooxygenase; Eicosanoids; Inflammation; Atherosclerotic cardiovascular disease; Prognosis; Humans;
Activation of TP receptors induces high release of PGI2 in coronary arteries of renal hypertensive rats
Keywords: پروستاسیکلین; Hypertension; Coronary arteries; Endothelial dysfunction; Cyclooxygenase; Prostacyclin;